149 Real-world outcomes of Osimertinib for EGFR-mutated advanced non-small cell lung cancer: a single-institution experience at a tertiary NHS Hospital

Lung Cancer 2026

View at publisher
Authors: Narmina Chamedova, Farasat Kazmi, Djoah Osborn, Keisha Machron, Guhan Shanmugasundaram, Pinelopi Gkogkou, Zacharias Tasigiannopoulos, Amy Forrest
DOI: 10.1016/j.lungcan.2026.109098
Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment HER2/EGFR in Cancer Research

Publication details

Journal / source
Lung Cancer
Volume
212
Pages
109098–109098
Publication date
1 February 2026
Language
EN